High-Dose Vitamin C Injection to Cancer Patients May Promote Thrombosis Through Procoagulant Activation of Erythrocytes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Keunyoung | - |
dc.contributor.author | Bae, Ok-Nam | - |
dc.contributor.author | Koh, Sung-Hee | - |
dc.contributor.author | Kang, Seojin | - |
dc.contributor.author | Lim, Kyung-Min | - |
dc.contributor.author | Noh, Ji-Yoon | - |
dc.contributor.author | Shin, Sue | - |
dc.contributor.author | Kim, Inho | - |
dc.contributor.author | Chung, Jin-Ho | - |
dc.date.accessioned | 2021-06-22T19:03:25Z | - |
dc.date.available | 2021-06-22T19:03:25Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2015-10 | - |
dc.identifier.issn | 1096-6080 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/17016 | - |
dc.description.abstract | Potential risk of high-dose vitamin C consumption is often ignored. Recently, gram-dose vitamin C is being intravenously injected for the treatment of cancer, which can expose circulating blood cells to extremely high concentrations of vitamin C. As well as platelets, red blood cells (RBCs) can actively participate in thrombosis through procoagulant activation. Here, we examined the procoagulant and prothrombotic risks associated with the intravenous injection of gram-dose vitamin C. Vitamin C (0.5-5mM) increased procoagulant activity of freshly isolated human RBCs via the externalization of phosphatidylserine (PS) to outer cellular membrane and the formation of PS-bearing microvesicles. PS exposure was induced by the dysregulation of key enzymes for the maintenance of membrane phospholipid asymmetry, which was from vitamin C-induced oxidative stress, and resultant disruption of calcium and thiol homeostasis. Indeed, the intravenous injection of vitamin C (0.5-1.0 g/kg) in rats in vivo significantly increased thrombosis. Notably, the prothrombotic effects of vitamin C were more prominent in RBCs isolated from cancer patients, who are at increased risks of thrombotic events. Vitamin C-induced procoagulant and prothrombotic activation of RBCs, and increased thrombosis in vivo. RBCs from cancer patients exhibited increased sensitivity to the prothrombotic effects of vitamin C, reflecting that intravenous gram-dose vitamin C therapy needs to be carefully revisited. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.title | High-Dose Vitamin C Injection to Cancer Patients May Promote Thrombosis Through Procoagulant Activation of Erythrocytes | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Bae, Ok-Nam | - |
dc.identifier.doi | 10.1093/toxsci/kfv133 | - |
dc.identifier.scopusid | 2-s2.0-84943777711 | - |
dc.identifier.wosid | 000365547300008 | - |
dc.identifier.bibliographicCitation | TOXICOLOGICAL SCIENCES, v.147, no.2, pp.350 - 359 | - |
dc.relation.isPartOf | TOXICOLOGICAL SCIENCES | - |
dc.citation.title | TOXICOLOGICAL SCIENCES | - |
dc.citation.volume | 147 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 350 | - |
dc.citation.endPage | 359 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.subject.keywordPlus | MICROVASCULAR ENDOTHELIAL-CELLS | - |
dc.subject.keywordPlus | I CLINICAL-TRIAL | - |
dc.subject.keywordPlus | ASCORBIC-ACID | - |
dc.subject.keywordPlus | PHOSPHATIDYLSERINE EXPOSURE | - |
dc.subject.keywordPlus | VENOUS THROMBOEMBOLISM | - |
dc.subject.keywordPlus | HYDROGEN-PEROXIDE | - |
dc.subject.keywordPlus | PHOSPHOLIPASE-D | - |
dc.subject.keywordPlus | IRON UPTAKE | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | PHARMACOKINETICS | - |
dc.subject.keywordAuthor | vitamin C | - |
dc.subject.keywordAuthor | thrombotic risk | - |
dc.subject.keywordAuthor | red blood cells | - |
dc.subject.keywordAuthor | procoagulant activation | - |
dc.subject.keywordAuthor | cancer patient | - |
dc.identifier.url | https://academic.oup.com/toxsci/article/147/2/350/1620914 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.